http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022238457-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3891c33f69124714595b835e4fd652e7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2206-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2206-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-342
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14
filingDate 2022-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecaed9ff965cbc09dc0f1cb98e761b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_590dd74eb3984c992e4ad447fc2560e9
publicationDate 2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022238457-A1
titleOfInvention Infusion site of a blood tubing system
abstract An infusion site for a blood tubing set, comprises a first (102) and a second (104) connection sites for connecting a first and a second tubing portion of the blood tubing set to the infusion site (100), and suitable to let a first and a second liquid enter the infusion site (100); and a third connection site (103) for connecting a third tubing portion of the blood tubing set to the infusion site (100) and suitable to let a third liquid exit the infusion site (100). The infusion site (100) further comprises a first main channel (120) in fluid communication to the first connection site (102) for conducting the first liquid through the infusion site (100); a second main channel (130) in fluid communication to the third connection site (103) for conducting the third liquid out from the infusion site (100); wherein the first main channel (120) is vertically offset to the second main channel (130) and the first main channel (120), the secondary channel (140) and the second main channel (130) are in fluid communication to each other. The infusion site (100) further comprises an inner turbulence chamber (150), located downstream from and in fluid communication to the first main channel (120) and the secondary channel (140) and located upstream and in fluid communication to the second main channel (130), and comprising an inlet deflector (160) suitable to deflect the fluids entering the infusion site (100) and a re-circulator (170) suitable to recirculate the fluid inside the infusion site (100).
priorityDate 2021-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014050614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009030973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020016319-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448814769

Total number of triples: 26.